Advertisement

Related Videos

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Advertisement

Advertisement




Feb
05
Today In Oncology
Addition of Palbociclib to Standard Therapy in Hormone Receptor–Positive, HER2-Positive Metastatic Breast Cancer
ASH 2025: Highlights in Relapsed/Refractory Multiple Myeloma
World Cancer Day 2026 UICCs Campaign United by Unique
Oxybutynin May Improve ADT-Induced Hot Flashes in Patients With Prostate Cancer
American College of Surgeons Publishes Annual NCDB Report
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo